Becton, Dickinson and Company (BVMF:B1DX34)

Market Cap	293.04B
Revenue (ttm)	116.39B
Net Income (ttm)	8.94B
Shares Out	n/a
EPS (ttm)	31.02
PE Ratio	32.77
Forward PE	12.65
Dividend	3.08 (1.51%)
Ex-Dividend Date	Dec 5, 2025

Volume	1
Average Volume	56
Open	204.33
Previous Close	202.64
Day's Range	204.33 - 204.33
52-Week Range	183.35 - 286.00
Beta	0.45
RSI	50.07
Earnings Date	Feb 5, 2026

About BVMF:B1DX34

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, va...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1897
• Employees: 70,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: B1DX34

Financial Performance

In 2025, BVMF:B1DX34's revenue was $21.84 billion, an increase of 8.24% compared to the previous year's $20.18 billion. Earnings were $1.68 billion, a decrease of -1.58%.

Financial numbers in USD